The U.S. Food and Drug Administration (FDA) recently approved a slew of new treatments for various public health ailments, including a drug for weight loss and management for the first time in seven years.

Officials gave the green light to the prescription drug semaglutide, under the brand name Wegovy, for adults struggling with obesity or being overweight who also have a second related condition, such as high blood pressure, type 2 diabetes, or high cholesterol.

Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more

Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens

It is administered as an injection to patients with Body Mass indexes (BMIs) in the overweight or obese categories.

Wegovy was tested in clinical trials featuring a placebo. Participants who were given Wegovy lost an average of 12.4 percent of their initial body weight.

Read more at The Hill.